Evidence and Guidance of Hepatitis C Therapy in Pregnancy – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“Hepatitis C remains a massive public health problem, but promise has arrived in direct-acting antivirals (DAAs).
In this review, the authors review the state of the evidence regarding hepatitis C therapy in pregnancy, arriving at a conclusion that while larger prospective trials are being conducted, shared-decision making for HepC therapy in pregnancy should be considered given the potential for pregnancy as a major window to combatting this infection. They also provide guidance on counseling about therapy, open registries, and ongoing trials.”
Title: Hepatitis C Treatment During Pregnancy: Time for a Practice Change
Authors: Karley Dutra, Jonathan M. Fenkel
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 16, 2026, 19:56Dina Ibrahem: Poor ICM vs. Poor TE
-
Oct 16, 2026, 19:47Sean Lauber: NIPT and Amniocentesis after PGT-A Reveal Few Abnormalities
-
Oct 16, 2026, 19:42Devyanshi Dixit: C-Section vs. Vaginal Birth – 2 Birth Paths, 2 Very Different Recoveries
-
Oct 16, 2026, 19:32Pawel Kordowitzki: Maternal Vitamin D Homeostasis, Pregnancy Outcomes and Offspring Health
-
Oct 16, 2026, 19:13Shizuko Takahashi: Our Study on Women’s Experiences of Assisted Reproductive Care in China Has Been Accepted by RBMO
-
Oct 16, 2026, 19:09ESHRE Announces ECRES-GESEA Reproductive Surgery Training and Certification in Slovenia
-
Oct 16, 2026, 18:20Kabita KB: What Happens if PLCZ1 Is Defective?
-
Oct 16, 2026, 18:12Partha Sarathi Das: From Reproductive Lifespan to Reproductive Healthspan
-
Oct 16, 2026, 18:05Joyce Harper: It Was a Pleasure to Give 2 Talks Celebrating World Menopause Day